Listed

Healthcare Services Group Inc

HCSGNasdaqCIK 731012HealthcareFiscal year ends Dec 31

Latest reported revenue, Q3 FY2026$479.6mRevenue, Q3 FY2026, three months to 2026-09-30$479.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 23, 2026.

Latest quarter: Q3 FY2026

Three months to Sep 30, 2026, against the same quarter a year earlier.

  • Revenue$479.6mRevenue, Q3 FY2026, three months to 2026-09-30$479.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Report this figure+3.3% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating marginnot reported (Operating income not reported)No year-earlier figure to compare
  • Net margin5.2%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $24.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Revenue: $479.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Report this figure−4.1 pts on a year earlier
  • Diluted EPS$0.36Diluted EPS, Q3 FY2026, three months to 2026-09-30$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Report this figure−39.0% on a year earlier
  • Free cash flow$28.1mFree cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $30.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-23, accession 0000731012-26-000059. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-23, accession 0000731012-26-000059. Derived: 9-month figure less the 6-month figure.Report this figure−59.8% on a year earlier

Last eight quarters

Full statements
Revenue$479.6mNet margin 5.2%
Diluted EPS$0.36, Q3 FY2026
Free cash flow$28.1m, Q3 FY2026
Healthcare Services Group Inc, key figures for the last eight quarters
Line itemUnitQ4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30Shape over the periods
Revenue$m438Revenue, Q4 FY2024, three months to 2024-12-31$437.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000731012-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure448Revenue, Q1 FY2025, three months to 2025-03-31$447.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-24, accession 0000731012-26-000031.Report this figure458Revenue, Q2 FY2025, three months to 2025-06-30$458.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-24, accession 0000731012-26-000046.Report this figure464Revenue, Q3 FY2025, three months to 2025-09-30$464.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Report this figure467Revenue, Q4 FY2025, three months to 2025-12-31$466.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000731012-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure463Revenue, Q1 FY2026, three months to 2026-03-31$462.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-24, accession 0000731012-26-000031.Report this figure471Revenue, Q2 FY2026, three months to 2026-06-30$470.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-24, accession 0000731012-26-000046.Report this figure480Revenue, Q3 FY2026, three months to 2026-09-30$479.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%2.7%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $11.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000731012-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $437.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000731012-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure3.8%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $17.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Revenue: $447.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-24, accession 0000731012-26-000031.Report this figure(7.1%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$32.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Revenue: $458.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-24, accession 0000731012-26-000046.Report this figure9.3%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $43.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Revenue: $464.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Report this figure6.7%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $31.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000731012-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $466.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000731012-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure5.6%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $26.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Revenue: $462.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-24, accession 0000731012-26-000031.Report this figure4.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $22.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Revenue: $470.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-24, accession 0000731012-26-000046.Report this figure5.2%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $24.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Revenue: $479.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)0.23Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-24, accession 0000731012-26-000031.Report this figure(0.44)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-24, accession 0000731012-26-000046.Report this figure0.59Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Report this figurenot reported (Diluted EPS not reported)0.37Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-24, accession 0000731012-26-000031.Report this figure0.32Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-24, accession 0000731012-26-000046.Report this figure0.36Diluted EPS, Q3 FY2026, three months to 2026-09-30$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-23, accession 0000731012-26-000059.Report this figure
Free cash flow$m34.8Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $36.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000731012-26-000009. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000731012-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure25.8Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $27.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-24, accession 0000731012-26-000031.Capital expenditure: $1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-24, accession 0000731012-26-000031.Report this figure27.4Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $28.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-24, accession 0000731012-26-000046. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-24, accession 0000731012-26-000046. Derived: 6-month figure less the 3-month figure.Report this figure70.0Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $71.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-23, accession 0000731012-26-000059. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-23, accession 0000731012-26-000059. Derived: 9-month figure less the 6-month figure.Report this figure16.0Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $17.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000731012-26-000009. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000731012-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure42.3Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $43.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-24, accession 0000731012-26-000031.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-24, accession 0000731012-26-000031.Report this figure20.2Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $21.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-24, accession 0000731012-26-000046. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-24, accession 0000731012-26-000046. Derived: 6-month figure less the 3-month figure.Report this figure28.1Free cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $30.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-23, accession 0000731012-26-000059. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-23, accession 0000731012-26-000059. Derived: 9-month figure less the 6-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.84bnNet margin 3.2%
Diluted EPS$0.81, FY2025
Free cash flow$139.2m, FY2025
Healthcare Services Group Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m1,642Revenue, FY2021, twelve months to 2021-12-31$1.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-16, accession 0000731012-24-000025.Report this figure1,690Revenue, FY2022, twelve months to 2022-12-31$1.69bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-14, accession 0000731012-25-000032.Report this figure1,671Revenue, FY2023, twelve months to 2023-12-31$1.67bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure1,716Revenue, FY2024, twelve months to 2024-12-31$1.72bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure1,837Revenue, FY2025, twelve months to 2025-12-31$1.84bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%3.0%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $48.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-16, accession 0000731012-24-000025.Revenue: $1.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-16, accession 0000731012-24-000025.Report this figure2.0%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $34.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-14, accession 0000731012-25-000032.Revenue: $1.69bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-14, accession 0000731012-25-000032.Report this figure2.3%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $38.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000731012-26-000009.Revenue: $1.67bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure2.3%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $39.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000731012-26-000009.Revenue: $1.72bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure3.2%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $59.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000731012-26-000009.Revenue: $1.84bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure
Diluted EPS$ per share0.65Diluted EPS, FY2021, twelve months to 2021-12-31$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-16, accession 0000731012-24-000025.Report this figure0.46Diluted EPS, FY2022, twelve months to 2022-12-31$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-14, accession 0000731012-25-000032.Report this figure0.52Diluted EPS, FY2023, twelve months to 2023-12-31$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure0.53Diluted EPS, FY2024, twelve months to 2024-12-31$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure0.81Diluted EPS, FY2025, twelve months to 2025-12-31$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure
Free cash flow$m31.4Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $37.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-16, accession 0000731012-24-000025.Capital expenditure: $5.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-16, accession 0000731012-24-000025.Report this figure(13.4)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-14, accession 0000731012-25-000032.Capital expenditure: $5.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-14, accession 0000731012-25-000032.Report this figure38.1Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $43.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000731012-26-000009.Capital expenditure: $5.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure24.5Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $30.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000731012-26-000009.Capital expenditure: $6.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure139Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $145.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000731012-26-000009.Capital expenditure: $5.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000731012-26-000009.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

By month, by reported value, last 24 monthsPurchases $0Sales $458.0k
Healthcare Services Group Inc, open-market insider transactions
DateInsiderTransactionSharesReported priceValueFiling
2026-10-26Bundick Jason JEVP/Gen. Counsel/Corp. Secty., Officer Sale18,239$25.11$458.0kForm 4

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Healthcare Services Group Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$279.4m11,375,365Reduced−83,231
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$124.8m5,080,313Added+234,180
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$74.7m3,040,374Reduced−79,171
STATE STREET CORP2026-06-30$71.6m2,916,008Added+96,883
AMERICAN CENTURY COMPANIES INC2026-06-30$65.4m2,661,455Added+153,028
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$62.9m2,562,011Added+517,415
DIMENSIONAL FUND ADVISORS LP2026-06-30$61.0m2,484,818Added+84,137
FMR LLC2026-06-30$56.4m2,296,772Added+329,978
AMERIPRISE FINANCIAL INC2026-06-30$55.4m2,255,190Added+89,446
ROYCE & ASSOCIATES LP2026-06-30$55.0m2,239,224Added+95,987

Recent filings

All 897 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Healthcare Services Group Inc, recent filings
FiledFormWhat it isAccession number
2026-10-2316:04 ET10-QQuarterly reportPeriod 2026-09-300000731012-26-000059
2026-10-2107:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000731012-26-000055
2026-10-0717:00 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000731012-26-000052
2026-07-2416:04 ET10-QQuarterly reportPeriod 2026-06-300000731012-26-000046
2026-07-2207:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000731012-26-000040
2026-05-2716:14 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000731012-26-000036
2026-04-2417:20 ET10-QQuarterly reportPeriod 2026-03-310000731012-26-000031
2026-04-2207:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000731012-26-000025
2026-04-1517:04 ETDEF 14AProxy statementPeriod 2026-05-260000731012-26-000021
2026-04-1317:28 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000731012-26-000015

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 13, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
731012
Tickers
HCSG
Exchange
Nasdaq
SIC code
8050 Services-Nursing & Personal Care Facilities
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
PA
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:40 ET. Listed shows no prices and gives no investment advice.